Skip to main content

Table 2 Maximum change in lipids and glucose metabolism in the alogliptin and control groups

From: Alogliptin ameliorates postprandial lipemia and postprandial endothelial dysfunction in non- diabetic subjects: a preliminary report

 

Control

Alogliptin

p

TG (mg/dl)

59.7 ± 7.8

48.3 ± 6.4

0.01

RLP-C (mg/dl)

6.1 ± 0.6

4.8 ± 0.7

0.02

ApoB-48 (μg/ml)

4.0 ± 0.4

2.8 ± 0.2

0.01

Glucose (mg/dl)

20.5 ± 2.4

20.4 ±3.9

0.51

Insulin (μIU/ml)

19.4 ± 6.3

18.2 ± 4.8

0.87

GLP-1 (pmol/l)

5.4 ± 1.3

10.2 ± 1.3

0.04

  1. Data are the mean ± SE. TG, triglyceride; RLP-C, remnant lipoprotein cholesterol; ApoB-48, apolipoprotein B-48; GLP-1, glucagon-like peptide-1.
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840